Literature DB >> 21756998

Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease.

Eric M Blalock1, Heather M Buechel, Jelena Popovic, James W Geddes, Philip W Landfield.   

Abstract

Alzheimer's disease (AD) is a devastating neurodegenerative disorder that threatens to reach epidemic proportions as our population ages. Although much research has examined molecular pathways associated with AD, relatively few such studies have focused on the disease's critical early stages. In a prior microarray study we correlated gene expression in hippocampus with degree of Alzheimer's disease and found close associations between upregulation of apparent glial transcription factor/epigenetic/tumor suppressor genes and incipient AD. The results suggested a new model in which AD pathology spreads along myelinated axons (Blalock et al., 2004). However, the microarray analyses were performed on RNA extracted from frozen hand-dissected hippocampal CA1 tissue blocks containing both gray and white matter, limiting the confidence with which transcriptional changes in gray matter could be distinguished from those in white matter. Here, we used laser capture microdissection (LCM) to exclude major white matter tracts while selectively collecting CA1 hippocampal gray matter from formalin-fixed, paraffin-embedded (FFPE) hippocampal sections of the same subjects assessed in our prior study. Microarray analyses of this gray matter-enriched tissue revealed many transcriptional changes similar to those seen in our past study and in studies by others, particularly for downregulated neuron-related genes. Additionally, the present analyses identified several previously undetected pathway alterations, including downregulation of molecules that stabilize ryanodine receptor Ca2+ release and upregulation of vasculature development. Conversely, we found a striking paucity of the upregulated changes in the putative glial and growth-related genes that had been strongly overrepresented in the prior mixed-tissue study. We conclude that FFPE tissue can be a reliable resource for microarray studies of brain tissue, that upregulation of growth-related epigenetic/transcription factors during incipient AD is predominantly localized in and around white matter (supporting our prior findings and model), and that novel alterations in vascular and ryanodine receptor-related pathways in gray matter are closely associated with incipient AD.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21756998      PMCID: PMC3163806          DOI: 10.1016/j.jchemneu.2011.06.007

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  80 in total

1.  A gene expression profile of Alzheimer's disease.

Authors:  J F Loring; X Wen; J M Lee; J Seilhamer; R Somogyi
Journal:  DNA Cell Biol       Date:  2001-11       Impact factor: 3.311

Review 2.  Adiposity indices and dementia.

Authors:  Deborah Gustafson
Journal:  Lancet Neurol       Date:  2006-08       Impact factor: 44.182

3.  Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissue.

Authors:  Renata A Coudry; Sibele I Meireles; Radka Stoyanova; Harry S Cooper; Alan Carpino; Xianqun Wang; Paul F Engstrom; Margie L Clapper
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

Review 4.  Gene expression omnibus: microarray data storage, submission, retrieval, and analysis.

Authors:  Tanya Barrett; Ron Edgar
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

5.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

6.  Preliminary comparison of quantity, quality, and microarray performance of RNA extracted from formalin-fixed, paraffin-embedded, and unfixed frozen tissue samples.

Authors:  Marshall S Scicchitano; Deidre A Dalmas; Melissa A Bertiaux; Shawn M Anderson; Leah R Turner; Roberta A Thomas; Rossana Mirable; Rogely W Boyce
Journal:  J Histochem Cytochem       Date:  2006-07-24       Impact factor: 2.479

Review 7.  RNA expression analysis from formalin fixed paraffin embedded tissues.

Authors:  Susan M Farragher; Austin Tanney; Richard D Kennedy; D Paul Harkin
Journal:  Histochem Cell Biol       Date:  2008-08-05       Impact factor: 4.304

Review 8.  Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease.

Authors:  R A Nixon; K I Saito; F Grynspan; W R Griffin; S Katayama; T Honda; P S Mohan; T B Shea; M Beermann
Journal:  Ann N Y Acad Sci       Date:  1994-12-15       Impact factor: 5.691

Review 9.  The role of calcium regulation in brain aging: reexamination of a hypothesis.

Authors:  Z S Khachaturian
Journal:  Aging (Milano)       Date:  1989-09

10.  AGEMAP: a gene expression database for aging in mice.

Authors:  Jacob M Zahn; Suresh Poosala; Art B Owen; Donald K Ingram; Ana Lustig; Arnell Carter; Ashani T Weeraratna; Dennis D Taub; Myriam Gorospe; Krystyna Mazan-Mamczarz; Edward G Lakatta; Kenneth R Boheler; Xiangru Xu; Mark P Mattson; Geppino Falco; Minoru S H Ko; David Schlessinger; Jeffrey Firman; Sarah K Kummerfeld; William H Wood; Alan B Zonderman; Stuart K Kim; Kevin G Becker
Journal:  PLoS Genet       Date:  2007-10-02       Impact factor: 5.917

View more
  81 in total

1.  Drosophila Shep and C. elegans SUP-26 are RNA-binding proteins that play diverse roles in nervous system development.

Authors:  Logan T Schachtner; Ismail E Sola; Daniel Forand; Simona Antonacci; Adam J Postovit; Nathan T Mortimer; Darrell J Killian; Eugenia C Olesnicky
Journal:  Dev Genes Evol       Date:  2015-08-14       Impact factor: 0.900

2.  Neuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain.

Authors:  Sarah C Hopp; Nathan A Bihlmeyer; John P Corradi; Charles Vanderburg; Angela M Cacace; Sudeshna Das; Timothy W Clark; Rebecca A Betensky; Bradley T Hyman; Eloise Hudry
Journal:  J Neurochem       Date:  2018-09-07       Impact factor: 5.372

3.  Interactions of early adversity with stress-related gene polymorphisms impact regional brain structure in females.

Authors:  Arpana Gupta; Jennifer Labus; Lisa A Kilpatrick; Mariam Bonyadi; Cody Ashe-McNalley; Nuwanthi Heendeniya; Sylvie Bradesi; Lin Chang; Emeran A Mayer
Journal:  Brain Struct Funct       Date:  2015-01-30       Impact factor: 3.270

Review 4.  Pathway analysis of the human brain transcriptome in disease.

Authors:  Tomas Kavanagh; James D Mills; Woojin S Kim; Glenda M Halliday; Michael Janitz
Journal:  J Mol Neurosci       Date:  2012-12-22       Impact factor: 3.444

5.  Transcriptional signatures mediated by acetylation overlap with early-stage Alzheimer's disease.

Authors:  J Vadnal; S Houston; S Bhatta; E Freeman; J McDonough
Journal:  Exp Brain Res       Date:  2012-07-19       Impact factor: 1.972

6.  Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease.

Authors:  Nicole C Berchtold; Marwan N Sabbagh; Thomas G Beach; Ronald C Kim; David H Cribbs; Carl W Cotman
Journal:  Neurobiol Aging       Date:  2014-04-02       Impact factor: 4.673

7.  Transcriptional signatures of brain aging and Alzheimer's disease: What are our rodent models telling us?

Authors:  Kendra E Hargis; Eric M Blalock
Journal:  Behav Brain Res       Date:  2016-05-04       Impact factor: 3.332

8.  CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation.

Authors:  Melissa J Alldred; Helen M Chao; Sang Han Lee; Judah Beilin; Brian E Powers; Eva Petkova; Barbara J Strupp; Stephen D Ginsberg
Journal:  Hippocampus       Date:  2018-02-12       Impact factor: 3.899

9.  Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients.

Authors:  Leonidas Chouliaras; Diego Mastroeni; Elaine Delvaux; Andrew Grover; Gunter Kenis; Patrick R Hof; Harry W M Steinbusch; Paul D Coleman; Bart P F Rutten; Daniel L A van den Hove
Journal:  Neurobiol Aging       Date:  2013-04-09       Impact factor: 4.673

Review 10.  Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.

Authors:  Alison E Mungenast; Sandra Siegert; Li-Huei Tsai
Journal:  Mol Cell Neurosci       Date:  2015-12-04       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.